Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regenerative Potential of Immature Necrotic Teeth
NCT03507556Active, not recruiting
- Sponsor
- Jordan University of Science and Technology
- Start
- Jun 2010
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metronidazole, ciprofloxacin and minocycline in apical periodontitis (AP) and pulp necrosis, sponsored by Jordan University of Science and Technology. Primary endpoint: Complete healing at 100 months. Started Jun 2010; status: active, not recruiting.
02
Drugs
metronidazoleciprofloxacinminocycline
03
Conditions
apical periodontitis (AP)pulp necrosis
Beyond the preview
Go deeper on NCT03507556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03507556.